Cintrifuse

Nichefire is an AI-powered marketing analytics company that develops a predictive cultural intelligence platform. The platform helps businesses activate and interpret online brand and consumer interactions to inform decision making. It uses artificial intelligence to gather and analyze social metrics, brand tactics, and consumer sentiment, and to optimize media channels for marketing and competitive insight. The system collects, sorts, and categorizes millions of posts, comments, and reactions in seconds, enabling the identification of emerging consumer trends and opportunities for growth.

Tembo develops a background engineering platform that automates routine tasks for software teams. Its always-on agents monitor systems, fix bugs automatically, and complete assigned tasks, enhancing pull request velocity and reducing manual workload.

LunchTable is a fan activation platform that transforms casual fans into brand ambassadors through targeted campaigns and data‑driven strategies. Its AI‑powered system creates and curates customized content calendars, manages fan onboarding, distributes content, and tracks performance, enabling brands to amplify messaging and build a loyal, engaged customer base.

Cloverleaf LLC offers a visualization and scenario-planning platform designed to enhance team management and employee development. Founded in 2015 and based in Covington, Kentucky, the platform analyzes employee data to provide insights into team dynamics by cross-mapping personality traits, skills, and organizational culture. This enables users, including agile practitioners, project managers, and human resource professionals, to position team members effectively, improve communication, and identify suitable candidates to boost productivity. Additionally, Cloverleaf's automated coaching features deliver personalized nudges through commonly used tools like Google Workspace, Microsoft Outlook, and Slack, fostering collaboration and performance improvements within teams.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Struxtion offers an online financing platform tailored for underserved commercial construction contractors. The platform aims to maintain the financial health of these contractors by providing cost-effective working capital solutions. It collects and analyzes project-related information to deliver optimal pricing, ultimately empowering contractors with the necessary financial support to thrive in their projects.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.